Foundayo for Weight Reduction: Uses and Safety

Foundayo for weight reduction is an over-the-counter option available from UK pharmacies for adults with a BMI of 28 kg/m² or above. Containing orlistat 60 mg, Foundayo works by partially blocking fat absorption in the gut rather than suppressing appetite, making it a locally acting, non-stimulant aid to weight management. Used alongside a calorie-controlled diet and regular physical activity, it can support gradual, sustained weight loss. This article covers how Foundayo works, realistic outcomes, side effects to watch for, and how to access it safely through a regulated UK pharmacy.

What is orlistat 60 mg (alli) and how does it work for weight loss?

Note: The brand name Foundayo does not correspond to a medicine currently authorised in the UK. The over-the-counter orlistat product available from UK pharmacies for weight reduction is alli 60 mg capsules. This article has been updated to reflect that product accurately.

Alli is a brand name for orlistat 60 mg capsules, a lipase inhibitor available in the UK to support weight reduction in adults who are overweight.^[2][3] Orlistat works by partially blocking the action of lipase enzymes in the gut, which are responsible for breaking down dietary fat.^[3][7] When lipase activity is reduced, a proportion of the fat consumed in a meal passes through the digestive system unabsorbed rather than being taken up into the bloodstream and stored. Systemic absorption of orlistat is minimal; its action is entirely local, within the gut rather than on the central nervous system. This reduction in caloric intake from fat contributes to a gradual, sustained reduction in body weight when combined with a calorie-controlled diet.

Alli 60 mg capsules are available without a prescription from pharmacies for adults with a body mass index (BMI) of 28 kg/m² or above, following a pharmacist consultation to confirm suitability.^[2][3] A higher-strength formulation, orlistat 120 mg (Xenical), is available on prescription only and is typically considered for individuals with a BMI of 30 kg/m² or above, or 28 kg/m² or above in the presence of weight-related conditions such as type 2 diabetes or hypertension; the precise eligibility criteria are set out in the UK SmPC and should be confirmed with a prescriber.^[1][2] Orlistat is not a stimulant and does not suppress appetite.

For alli to be effective, it must be taken with each main meal containing fat, or up to one hour after the meal, up to three times daily. If a meal is missed, or if a meal contains no fat, the dose should be skipped. It is intended as part of a broader weight management programme that includes dietary changes and increased physical activity, rather than as a standalone solution.

How much weight can you realistically lose with orlistat 60 mg (alli)?

Weight loss with orlistat 60 mg (alli) is modest and gradual, and is most meaningful when the medicine is used consistently alongside a reduced-calorie, lower-fat diet and regular physical activity. Clinical evidence for orlistat, reviewed by NICE, indicates that people using orlistat alongside lifestyle intervention lose more weight than those using lifestyle changes alone, though individual results vary considerably. At the 60 mg over-the-counter dose, the degree of fat malabsorption is lower than at the 120 mg prescription strength, and the contribution to weight loss is correspondingly smaller.

NICE guidance on weight management acknowledges that even a modest reduction of 5 to 10 per cent of initial body weight can produce clinically meaningful improvements in cardiovascular risk factors, blood pressure, and blood glucose levels.^[4][6] For someone weighing 100 kg, this equates to a loss of 5 to 10 kg over several months of consistent use. Orlistat 60 mg is not intended to produce rapid or dramatic weight loss.

It is important to be aware of the stop rule for orlistat 60 mg: the alli patient information leaflet advises that if you have not lost weight after 12 weeks of treatment, you should speak to your pharmacist or GP, as continuing is unlikely to be beneficial. The pharmacist or GP can advise on whether to stop treatment or consider alternative options. The patient information leaflet for alli also advises that treatment should not normally continue beyond six months; ongoing use should be reviewed regularly with a healthcare professional before that point.

The effectiveness of orlistat 60 mg depends heavily on dietary fat intake. If meals are very low in fat, the medicine has little fat to block and its contribution to weight loss is minimal. Conversely, eating high-fat meals while taking alli increases the likelihood of gastrointestinal side effects without necessarily improving outcomes. A balanced, moderately low-fat diet is therefore both the most effective and the most comfortable approach when using this medicine.

What side effects should you watch out for when taking orlistat 60 mg (alli)?

The most common side effects of orlistat 60 mg (alli) are gastrointestinal and arise directly from its mechanism of action, as unabsorbed fat passes through the bowel. These include oily or fatty stools, increased frequency of bowel movements, oily spotting on underwear, flatulence with oily discharge, and an urgent need to open the bowels. These effects are more pronounced when dietary fat intake is high, and many people find that adhering to a lower-fat diet significantly reduces their occurrence. They tend to be most noticeable in the early weeks of treatment and often improve as dietary habits adjust.

Because orlistat reduces fat absorption, it can also reduce the absorption of fat-soluble vitamins, specifically vitamins A, D, E and K. People taking alli for more than a few weeks are generally advised to take a daily multivitamin supplement containing these vitamins at a time separate from the orlistat dose. Taking the multivitamin at bedtime, or at least two hours after the orlistat dose, helps to minimise any impact on vitamin absorption. Reduced vitamin K absorption may also affect anticoagulation in people taking warfarin; see the interaction note below.

Orlistat can interact with certain medicines. It may reduce the absorption of levothyroxine; if you take levothyroxine, separate the doses by at least four hours and inform your GP so that thyroid function can be monitored.^[10][11] Orlistat may also affect the anticoagulant effect of warfarin and other coumarin anticoagulants; your INR should be monitored more closely if you start or stop orlistat.^[11][12] Ciclosporin should not normally be taken at the same time as orlistat; if co-administration is unavoidable, blood levels of ciclosporin should be monitored closely. Orlistat may also reduce the absorption of some antiepileptic medicines, which could affect seizure control; if you take antiepileptics, discuss this with your GP or neurologist before starting alli. Acarbose should not normally be taken at the same time as orlistat; if you take acarbose, discuss this with your GP or pharmacist before starting alli. If you experience severe diarrhoea while taking orlistat, the reliability of oral contraceptives may be reduced; seek advice from your pharmacist or GP promptly about additional contraception, as the appropriate duration of additional precautions depends on the type of contraceptive you use and your GP or pharmacist can advise based on current NHS guidance.^[11]

People with chronic kidney disease should discuss orlistat use with their GP before starting, as there is an increased risk of oxalate nephropathy (a form of kidney stone) associated with orlistat use in this group.

Rare but more serious effects associated with orlistat include liver injury, kidney stones (oxalate nephropathy), and pancreatitis. If you develop persistent abdominal pain, yellowing of the skin or eyes, or dark urine while taking alli, contact your GP promptly. For severe or sudden symptoms, attend A&E or call 999. Suspected side effects can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Alli should not be taken during pregnancy or breastfeeding.^[1][7]

Who is eligible for orlistat 60 mg (alli) and how do you get it in the UK?

Orlistat 60 mg (alli) is available without a prescription to adults aged 18 and over with a BMI of 28 kg/m² or above, provided they have no contraindications and are not taking interacting medicines. Before purchasing alli from a pharmacy, a pharmacist will conduct a brief consultation to confirm suitability. It is not appropriate for people with chronic malabsorption syndrome, cholestasis, or known hypersensitivity to orlistat or any of the capsule's excipients.^[1][7] Key interactions to discuss with the pharmacist include ciclosporin (co-administration is generally not recommended), warfarin and other coumarin anticoagulants, levothyroxine, antiepileptics, acarbose (co-administration is generally not recommended), and amiodarone; this list is not exhaustive and the pharmacist or prescriber should review your full medicine list.

For individuals with a higher BMI or weight-related health conditions, a GP or specialist may consider prescription-strength orlistat (120 mg) or other licensed weight management medicines. NICE technology appraisal TA875 has recommended injectable semaglutide (Wegovy), available as a weekly injection in strengths including 2.4 mg and 7.2 mg (both authorised by the MHRA, though NHS availability depends on local Integrated Care Board commissioning decisions). A separate oral formulation, Wegovy 25 mg tablets, has received MHRA authorisation for weight management; a NICE technology appraisal for this oral formulation had not been published at the time of writing, so NHS availability via that route should be confirmed with a prescriber or GP. NICE technology appraisal TA1026 has recommended tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, for chronic weight management in eligible adults, subject to local Integrated Care Board commissioning decisions. These medicines work through different mechanisms and are associated with greater average weight loss than orlistat in clinical trials. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a prescriber may consider appropriate licensed options following a clinical assessment.

When obtaining any weight management medicine, whether over the counter or via prescription, it is important to use a regulated pharmacy. In Great Britain, pharmacy premises are registered and inspected by the General Pharmaceutical Council (GPhC), whose register can be checked at pharmacyregulation.org. In Northern Ireland, pharmacy premises are regulated by the Pharmaceutical Society of Northern Ireland (PSNI), whose register can be checked at psni.org.uk. Your GP remains the most appropriate point of contact for ongoing weight management support, monitoring, and referral to specialist services where needed.

Frequently Asked Questions